Groowe Groowe / Newsroom / TEVA
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

TEVA News

Teva Pharmaceutical Industries Limited American Depositary Shares

CoreWeave Class Action: CoreWeave, Inc. ($CRWV) Investors Are Notified of the Pending Securities Fraud Lawsuit and to Contact BFA Before the Upcoming March 13 Legal Deadline Ready to Announce with Confidence?

newsfilecorp.com
CRWV SCZ OPEN TSLA TEVA HUBG PFSI PLUG

Asthma Drugs Market to Reach USD 41.18 Billion by 2035 | Biologic Therapies Accelerate Shift Toward Targeted Treatment Says Astute Analytica

globenewswire.com
SNY AMGN AZN GSK TEVA CHKP

Medincell’s ISS ESG Corporate Rating Upgraded

businesswire.com
TEVA

La notation ESG de Medincell relevée par ISS

businesswire.com
TEVA

MedImpact Offers Humira Biosimilar 95% Below the Cost of Humira to Any Hospital or Pharmacy

businesswire.com
TEVA

$12 Bn Private LTE/5G Network Market Forecasts, 2025-2026 & 2030: Insights from 35 New Executive Interviews with Market Leading Companies

globenewswire.com
ERIC NOK MSFT AMZN SWKS AVGO QCOM INTC CSCO HPE SNPS AMAT LRCX KLAC ASML MU WDC SE NVDA AMD MRVL NXPI QRVO ON ADI TXN MCHP INFY IBM ORCL SAP ACN CTAS CDNS GLW AVNT ATOS NTES BABA JD PDD IQ BIDU HTHT BILI VIPS NIO LI XPEV RIVN LCID TSLA F GM STLA CHPT PLTR SNOW DDOG CRM NOW PANW FTNT ZS CRWD MDB PYPL COIN UPST SOFI AFRM HOOD ETSY GOOG HPQ DELL SMCI ALGN IDXX REGN VRTX GILD AMGN BMY PFE MRK JNJ ABBV LLY BIIB AZN SNY TEVA BMRN EXPE BKNG MAR H IHG WYNN LVS MGM CCL RCL NCLH AAL DAL UAL LUV BA GD LMT RTX HON CAT DE GE MMM ROK EMR ILMN MELI ADBE GOOGL AAPL T VZ TMUS CMCSA CHTR

COVID-19 Diagnostic Research Report 2026: Market Forecast 2025-2029 with Executive and Consultant Guides

globenewswire.com
ABT BDX BIO CDNA CUE DHR GILD HOLX ILMN JNJ LAB LMT LULU MRNA ON ORGO OTIS PFE QCOM QGEN QDEL REGN RTX SIGA SNPS TCOM TDOC TEVA TMO TSLA VRTX XOM

Medincell - UZEDY ®: Net Sales Increased from $117M in 2024 to $191M in 2025 (+63%)

businesswire.com
TEVA

Medincell - UZEDY ® : croissance des ventes nettes de 117 M$ en 2024 à 191 M$ en 2025 (+63%)

businesswire.com
TEVA

Global Glioma Market Growth Driven by Therapeutic Innovations and Aging Population

globenewswire.com
MRK AMGN PFE TEVA SUN